About Novartis Oncology
Novartis Oncology in Estonia
About Novartis Oncology Estonia
Novartis Oncology Estonia is providing innovative oncology products in line with the EU activities. We do our best to help people to get access to effective treatments. According to the local regulations, we manage to get new products to the market quickly as well as to provide compassionate use programs and phase IV clinical studies.
Our Focus
- Haematology (Glivec, Tasigna, Exjade)
- Breast Cancer (Femara)
- GI Cancers (Glivec, Sandostatin LAR)
- Bone Metastasis (Zometa)
Contact Information
Address:
Novartis Pharma Services Inc Eesti Filiaal
Peterburi tee 47
11415 Tallinn
Estonia
Telephone: +372 606 2404
Novartis Oncology Estonia
Novartis Oncology Estonia turustab EL riikides kasutatavaid innovatiivseid vähiravimeid. Me anname endast parima, et inimesed saaksid efektiivset ravi. Kooskõlas kohalike seadustega püüame uued ravimid kiiresti Eestis kättesaadavaks muuta, teeme asendusravi programme ning IV faasi kliinilisi uuringuid.
Eristumine / Teenused / Huvid
- Hematoloogia (Glivec, Tasigna, Exjade)
- Rinnavähk (Femara)
- Seedetrakti kasvajad (Glivec, Sandostatin LAR)
- Luumetastaasid (Zometa)
Kontaktinfo
Aadress:
Novartis Pharma Services Inc Eesti Filiaal
Peterburi tee 47
11415 Tallinn
Eesti
Telefon: +372 606 2404
SEARCH OUR WEBSITES
PRODUCTS
At Novartis Oncology, we strive to provide a broad range of innovative, practical solutions and authoritative resource therapies.
CAREERS AT NOVARTIS
Our success depends entirely on the creativity, performance and achievement of our associates at all levels.
RESEARCH INNOVATION
Novartis maintains the most promising oncology drug pipeline in the industry to treat and help people around the world.